Professor Alessio Lanna is a distinguished immunologist and molecular biologist renowned for his pioneering research in immune system ageing. He holds a Full Professorship at University College London (UCL) and serves as the CEO and founder of Sentcell, a biotechnology company focused on developing therapies to reverse cellular ageing.

Dr. Lanna's groundbreaking work includes the discovery of a novel telomere transfer mechanism between immune cells, which has the potential to rejuvenate senescent T cells and enhance immune memory. This mechanism involves the transfer of telomeres from antigen-presenting cells to T lymphocytes via extracellular vesicles, extending the lifespan and functionality of these critical immune cells.